Home > India > Covaxin’s developer Bharat Biotech issues statement after Anil Vij tests positive for COVID-19
opoyicentral
Opoyi Central

3 years ago .Hyderabad, Telangana, India

Covaxin’s developer Bharat Biotech issues statement after Anil Vij tests positive for COVID-19

  • Covaxin's clinical trials are based on a two-day schedule, given 28 days apart, Bharat Biotech said in a statement
  • Its efficacy will be determined 14 days post the second dose, it added
  • Anil Vij was given the first dose on November 20

Written by:
Published: December 05, 2020 08:12:05 Hyderabad, Telangana, India

Haryana Health Minister Anil Vij, who was administered the trial dose of COVID-19 vaccine Covaxin, announced on Saturday that he had tested positive for COVID-19. Covaxin is an indigenous coronavirus vaccine developed by Hyderabad-based Bharat Biotech.

In a statement issued on Saturday, the company said Covaxin’s clinical trials are based on a two-day schedule, given 28 days apart, ANI reported. “The vaccine efficacy will be determined 14 days post the second dose,” it said.

Vij was administered the first dose of the vaccine on November 20.

“Covaxin has been designed to be efficacious when subjects receive both doses,” Bharat Biotech’s statement read.

Also read: PM Narendra Modi visits Bharat Biotech’s facility in Hyderabad

The phase 3 clinical trial of the vaccine is “double-blinded and randomised,” the company said. Half of the participants receive the vaccine and the other half receive a placebo, it added. 

Related Articles

ADVERTISEMENT

© Copyright 2023 Opoyi Private Limited. All rights reserved